Synthetic paclitaxel-octreotide conjugate reverses the resistance of paclitaxel in A2780/Taxol ovarian cancer cell line.
Shen Y, Zhang XY, Chen X, Fan LL, Ren ML, Wu YP, Chanda K, Jiang SW.
Oncol Rep. 2017 Jan;37(1):219-226.
- DOI:
http://dx.doi.org/10.3892/or.2016.5260
